BerlinDA, GulickRM, MartinezFJ: Severe Covid-19. N Engl J Med, 2020; 383:2451–2460.
2.
DionneJC, JohnstoneJ, SmithO, et al.: Content analysis of bowel protocols for the management of constipation in adult critically ill patients. J Crit Care, 2020; 58:98–104.
3.
KatakamiN, HaradaT, MurataT, et al.: Randomized Phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer. J Clin Oncol, 2017; 35:3859–3866.
4.
HaleM, WildJ, ReddyJ, et al.: Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): Two multicentre, phase 3, double-blind, randomised, parallel-group trials. Lancet Gastroenterol Hepatol, 2017; 2:555–564.
5.
Ramírez-SalinasGL, Martínez-ArchundiaM, Correa-BasurtoJ, García-MachorroJ: Repositioning of ligands that target the spike glycoprotein as potential drugs for SARS-CoV-2 in an in silico study. Molecules, 2020; 25:5615.
